Channels Pharmacokinetics of twice-daily versus once-daily dosing with granular slow-release para-aminosalicylic acid in adults on second-line anti-tuberculosis and antiretroviral treatment
Pharmacokinetics and dosing rationale of Para-Aminosalicylic acid in children and the evaluation of the in vitro metabolism of Ethionamide, Terizidone and Para-aminosalicylic acid
Pharmacokinetic study of anti-tb drug para-aminosalicylic acid and its metabolites: a possible relationship with the development of toxicity
A critical appraisal of the clinical pharmacokinetics of isoniazid
In vitro assessment of some traditional medications used in South Africa for pharmacokinetics drug interaction potential
The pharmacokinetics of lopinavir in HIV-infected adults receiving rifampicin with adjusted doses of lopinavir
Population pharmacokinetic modelling for dose optimization of esomeprazole to treat early-onset preeclampsia
A comparison of treatment response in two cohorts of once daily HAART and twice daily HAART in a sample population in Gaborone, Botswana
Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
Antimalarial activity and pharmacokinetic properties of new chemical entities
Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients
Variability in the pharmacokinetics of rifapentine in South African tuberculosis patients : a classical and population approach
The role of the pharmacokinetics, host folate levels and parasite mutations in the in vivo efficacy of pyrimethamine-sulfadoxine against Plasmodium falciparum
Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
A pharmacokinetic and antimalarial efficacy evaluation of pyridodibemequines and their metabolites
A rising-dose tolerance study in health human subjects, examining increasing doses of chlorproguanil with a constant dose of dapsone
Pharmacogenomics and pharmacokinetics of dolutegravir and tenofovir in Southern Africans living with HIV
The antiplasmodial, toxicity and pharmacokinetic properties of synthetic derivatives of the natural product Curcumin
Population pharmacokinetic modelling to address the gaps in knowledge of commonly used HIV and TB drugs in children
Pharmacogenomics and pharmacokinetics of antiretroviral drugs and their associations with metabolic complications in HIV-infected Black South Africans
Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated Falciparum malaria
Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
Clinical, pharmacokinetic, and genetic determinants of change in serum creatinine among Southern Africans on dolutegravir based antiretroviral therapy
Characterizing population pharmacokinetic/pharmacodynamic relationships in pulmonary tuberculosis infected adults using nonlinear mixed effects modelling
Drug-drug interactions between antiretrovirals and fluconazole in HIV-infected patients
